<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101473576</journal-id>
<journal-id journal-id-type="pubmed-jr-id">36343</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Aging Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Aging Sci</journal-id>
<journal-title-group>
<journal-title>Current aging science</journal-title>
</journal-title-group>
<issn pub-type="ppub">1874-6098</issn>
<issn pub-type="epub">1874-6128</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29552989</article-id>
<article-id pub-id-type="pmc">6519136</article-id>
<article-id pub-id-type="doi">10.2174/1874609811666180223154436</article-id>
<article-id pub-id-type="manuscript">NIHMS1027721</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>At the Crossroads Between Neurodegeneration and Cancer: A Review of Overlapping Biology and Its Implications</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Houck</surname>
<given-names>Alexander L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Seddighi</surname>
<given-names>Sahba</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Driver</surname>
<given-names>Jane A.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A3">4</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA</aff>
<aff id="A2"><label>2</label>Clinical and Translational Neuroscience Unit, Laboratory of Behavioral Neuroscience, National Institute on Aging (NIA), National Institutes of Health (NIH), Baltimore, MD, USA</aff>
<aff id="A3"><label>3,4</label>Geriatric Research Education and Clinical Center, VA Boston Healthcare System and the Division of Aging, Department of Medicine, Brigham and Women â€˜s Hospital, Harvard Medical School (J.A.D.), Boston, MA, USA</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Address correspondence to this author at the Geriatric Research Education and Clinical Center, VA Boston Healthcare System 150 S. Huntington Ave. Boston, MA 02130, USA; Tel: 617-525-7946; Fax: 617-525-7739; <email>Jane.Driver@va.gov</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P45">CONFLICT OF INTEREST</p>
<p id="P46">The authors declare no conflict of interest, financial or otherwise.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>7</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>5</month>
<year>2019</year>
</pub-date>
<volume>11</volume>
<issue>2</issue>
<fpage>77</fpage>
<lpage>89</lpage>
<!--elocation-id from pubmed: 10.2174/1874609811666180223154436-->
<abstract id="ABS1">
<sec id="S1">
<title>Background:</title>
<p id="P1">A growing body of epidemiologic evidence suggests that neurodegenerative diseases occur less frequently in cancer survivors, and vice versa. While unusual, this inverse comorbidity is biologically plausible and could be explained, in part, by the evolutionary tradeoffs made by neurons and cycling cells to optimize the performance of their very different functions. The two cell types utilize the same proteins and pathways in different, and sometimes opposite, ways. However, cancer and neurodegeneration also share many pathophysiological features.</p>
</sec>
<sec id="S2">
<title>Objective:</title>
<p id="P2">In this review, we compare three overlapping aspects of neurodegeneration and cancer.</p>
</sec>
<sec id="S3">
<title>Methods:</title>
<p id="P3">First, we contrast the priorities and tradeoffs of dividing cells and neurons and how these manifest in disease. Second, we consider the hallmarks of biological aging that underlie both neurodegeneration and cancer. Finally, we utilize information from genetic databases to outline specific genes and pathways common to both diseases.</p>
</sec>
<sec id="S4">
<title>Conclusions:</title>
<p id="P4">We argue that a detailed understanding of the biologic and genetic relationships between cancer and neurodegeneration can guide future efforts in designing disease-modifying therapeutic interventions. Lastly, strategies that target aging may prevent or delay both conditions.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Aging</kwd>
<kwd>neurodegeneration</kwd>
<kwd>carcinogenesis</kwd>
<kwd>trade-offs</kwd>
<kwd>hallmarks</kwd>
<kwd>neurons</kwd>
<kwd>dividing cells</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>